2012•PubMedRequires access
Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer.
Masaru Morita, Yasushi Toh, Hiroshi Saeki, Masahiko Sugiyama, Kippei Ohgaki, Shin‐ichiro Maehara, Kazuhito Minami, Yasuharu Ikeda, Yoshihisa Sakaguchi, Takeshi Okamura, Satoru Uehara, Yoshihiko Maehara
Open publisher page 17 citations
Abstract
AIM: To clarify the clinical significance of definitive chemoradiotherapy (CRT) and CRT followed by esophagectomy for cT4 esophageal cancer. PATIENTS AND METHODS: The treatment results for cT4 esophageal cancer were examined in 81 patients who received definitive CRT [radiation 50-70 Gy, cisplatin and 5-fluorouracil; group I] and 19 patients who underwent esophagectomy after preoperative CRT [40Gy, Group II]. RESULTS: Among the 81 patients in group I, toxicities (grade 3 or 4) were observed in 32 patients, while partial response and complete response were recognized in 8 and 47 patients, respectively. Of the 19 group II patients, an R0 resection was performed in 16 patients, and the mortality rate was 5%. The 5-year survival rates were 19% and 42% in groups I and II, respectively. CONCLUSION: Long-term survival can be expected after multimodal therapy, even for patients with cT4 esophageal cancer. Esophagectomy is therefore a valid treatment option when down-staging can be achieved.